Page 32 - manuscript_ijb05590

References
1. Day CP, Merlino G, Van Dyke T. Preclinical mouse cancer models: a maze of
opportunities and challenges. Cell. 2015;163(1):39-53.
doi:10.1016/j.cell.2015.08.068

2. Kim JW, Ho WJ, Wu BM. The role of the 3D environment in hypoxia-induced
drug and apoptosis resistance. Anticancer Res. 2011;31(10):3237-3245.

3. Loessner D, Stok KS, Lutolf MP, Hutmacher DW, Clements JA, Rizzi SC.
Bioengineered 3D platform to explore cell–ECM interactions and drug resistance
of epithelial ovarian cancer cells. Biomaterials. 2010;31(32):8494-8506.
doi:10.1016/j.biomaterials.2010.07.064

4. Katt ME, Placone AL, Wong AD, Xu ZS, Searson PC. In vitro tumor models:
advantages, disadvantages, variables, and selecting the right platform. Front
Bioeng Biotechnol. 2016;4:12. doi:10.3389/fbioe.2016.00012

5. Trujillo-de Santiago G, Flores-Garza BG, Tavares-Negrete JA, et al. The tumor-
on-chip: recent advances in the development of microfluidic systems to
recapitulate the physiology of solid tumors. Materials. 2019;12(18):2945.
doi:10.3390/ma12182945

6. Winters IP, Murray CW, Winslow MM. Towards quantitative and multiplexed in
vivo functional cancer genomics. Nat Rev Genet. 2018;19(12):741-755.
doi:10.1038/s41576-018-0053-7

7. Yoshida GJ. Applications of patient-derived tumor xenograft models and tumor
organoids. J Hematol OncolJ Hematol Oncol. 2020;13(1):4. doi:10.1186/s13045-
019-0829-z

8. Abdolahi S, Ghazvinian Z, Muhammadnejad S, Saleh M, Asadzadeh Aghdaei H,
Baghaei K. Patient-derived xenograft (PDX) models, applications and challenges
in cancer research. J Transl Med. 2022;20(1):206. doi:10.1186/s12967-022-
03405-8

9. James Kirkpatrick C, Fuchs S, Iris Hermanns M, Peters K, Unger RE. Cell culture
models of higher complexity in tissue engineering and regenerative medicine.
Biomaterials. 2007;28(34):5193-5198. doi:10.1016/j.biomaterials.2007.08.012

10. Nolan J, Pearce OMT, Screen HRC, Knight MM, Verbruggen SW. Organ-on-a-
Chip and Microfluidic Platforms for Oncology in the UK. Cancers.
2023;15(3):635. doi:10.3390/cancers15030635

11. Li Z, Li Q, Zhou C, et al. Organoid-on-a-chip: current challenges, trends, and
future scope toward medicine. Biomicrofluidics. 2023;17(5):51505.
doi:10.1063/5.0171350

31